Drug or technology

ExAblate MRgFUS

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · INTERVENTIONAL STUDY

Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas

ClinicalTrials.gov

Registry record of a completed single-arm, non-randomized device study with no results posted; design and enrollment are documented but outcomes remain unreported.

PreliminaryInSightec NCT02794558 ExAblate MRgFUS

Reported

Planned enrollment91

Study phaseNA

Primary outcome measureIncidence and severity of adverse events, 5…

SEP 8, 2026 · PHASE 2 TRIAL

Study of ExAblate Focused Ultrasound Ablation of Breast Cancer

ClinicalTrials.gov

Phase 2, single-arm, non-randomized registry record with no results posted; describes planned safety and histopathological assessment in a small cohort without comparator or outcome data.

PreliminaryInSightec NCT01620359 ExAblate MRgFUS

Reported

Sample size14

PhasePhase 2

Primary outcome measure 1Adverse Events, 5 weeks post treatment